Trial Outcomes & Findings for Cardiometabolic Effects of Pecans as a Snack (NCT NCT05071807)
NCT ID: NCT05071807
Last Updated: 2025-02-25
Results Overview
Measured by brachial ultrasound and expressed as percentage points of change in arterial diameter
COMPLETED
PHASE2
138 participants
12 weeks
2025-02-25
Participant Flow
Participant milestones
| Measure |
Pecan Group
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Overall Study
STARTED
|
69
|
69
|
|
Overall Study
COMPLETED
|
62
|
68
|
|
Overall Study
NOT COMPLETED
|
7
|
1
|
Reasons for withdrawal
| Measure |
Pecan Group
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
4
|
0
|
|
Overall Study
Unrelated medical issues
|
3
|
0
|
|
Overall Study
Relocated
|
0
|
1
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Pecan Group
n=69 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=69 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
Total
n=138 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
46 years
STANDARD_DEVIATION 12 • n=69 Participants
|
46 years
STANDARD_DEVIATION 14 • n=69 Participants
|
46 years
STANDARD_DEVIATION 13 • n=138 Participants
|
|
Sex: Female, Male
Female
|
45 Participants
n=69 Participants
|
36 Participants
n=69 Participants
|
81 Participants
n=138 Participants
|
|
Sex: Female, Male
Male
|
24 Participants
n=69 Participants
|
33 Participants
n=69 Participants
|
57 Participants
n=138 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United States
|
69 participants
n=69 Participants
|
69 participants
n=69 Participants
|
138 participants
n=138 Participants
|
|
Weight
|
84.3 kg
STANDARD_DEVIATION 12.5 • n=69 Participants
|
85.2 kg
STANDARD_DEVIATION 14.3 • n=69 Participants
|
84.8 kg
STANDARD_DEVIATION 13.4 • n=138 Participants
|
|
Waist circumference
|
97.2 cm
STANDARD_DEVIATION 8.8 • n=69 Participants
|
98.8 cm
STANDARD_DEVIATION 10.8 • n=69 Participants
|
98.0 cm
STANDARD_DEVIATION 9.9 • n=138 Participants
|
|
Pulse wave velocity
|
7.1 m/s
STANDARD_DEVIATION 1.3 • n=69 Participants
|
7.2 m/s
STANDARD_DEVIATION 1.2 • n=69 Participants
|
7.2 m/s
STANDARD_DEVIATION 1.3 • n=138 Participants
|
|
Flow mediated dilation
|
7.2 percent point change in arterial diamete
STANDARD_DEVIATION 4.0 • n=69 Participants
|
6.1 percent point change in arterial diamete
STANDARD_DEVIATION 3.3 • n=69 Participants
|
6.6 percent point change in arterial diamete
STANDARD_DEVIATION 3.7 • n=138 Participants
|
|
LDL-C
|
118 mg/dL
STANDARD_DEVIATION 34 • n=69 Participants
|
116 mg/dL
STANDARD_DEVIATION 28 • n=69 Participants
|
117 mg/dL
STANDARD_DEVIATION 31 • n=138 Participants
|
|
HDL-C
|
54 mmHg
STANDARD_DEVIATION 14 • n=69 Participants
|
52 mmHg
STANDARD_DEVIATION 13 • n=69 Participants
|
53 mmHg
STANDARD_DEVIATION 13.4 • n=138 Participants
|
|
Triglycerides
|
109 mmHg
STANDARD_DEVIATION 67 • n=69 Participants
|
116 mmHg
STANDARD_DEVIATION 47 • n=69 Participants
|
113 mmHg
STANDARD_DEVIATION 58 • n=138 Participants
|
|
LDL subclasses
Large
|
373 nmol/L
STANDARD_DEVIATION 251 • n=69 Participants
|
329 nmol/L
STANDARD_DEVIATION 194 • n=69 Participants
|
351 nmol/L
STANDARD_DEVIATION 225 • n=138 Participants
|
|
LDL subclasses
Medium
|
366 nmol/L
STANDARD_DEVIATION 267 • n=69 Participants
|
312 nmol/L
STANDARD_DEVIATION 255 • n=69 Participants
|
339 nmol/L
STANDARD_DEVIATION 261 • n=138 Participants
|
|
LDL subclasses
Small
|
623 nmol/L
STANDARD_DEVIATION 435 • n=69 Participants
|
698 nmol/L
STANDARD_DEVIATION 353 • n=69 Participants
|
660 nmol/L
STANDARD_DEVIATION 396 • n=138 Participants
|
|
LDL subclasses
Total LDL particle count
|
1362 nmol/L
STANDARD_DEVIATION 399 • n=69 Participants
|
1339 nmol/L
STANDARD_DEVIATION 339 • n=69 Participants
|
1350 nmol/L
STANDARD_DEVIATION 396 • n=138 Participants
|
|
HDL subclasses
Large
|
2.5 µmol/L
STANDARD_DEVIATION 1.7 • n=69 Participants
|
2.3 µmol/L
STANDARD_DEVIATION 1.4 • n=69 Participants
|
2.4 µmol/L
STANDARD_DEVIATION 1.6 • n=138 Participants
|
|
HDL subclasses
Medium
|
4.0 µmol/L
STANDARD_DEVIATION 1.8 • n=69 Participants
|
4.4 µmol/L
STANDARD_DEVIATION 2.4 • n=69 Participants
|
4.2 µmol/L
STANDARD_DEVIATION 2.1 • n=138 Participants
|
|
HDL subclasses
Small
|
14.2 µmol/L
STANDARD_DEVIATION 2.8 • n=69 Participants
|
14.0 µmol/L
STANDARD_DEVIATION 3.4 • n=69 Participants
|
14.1 µmol/L
STANDARD_DEVIATION 3.1 • n=138 Participants
|
|
HDL subclasses
HDL total particle count
|
20.7 µmol/L
STANDARD_DEVIATION 2.6 • n=69 Participants
|
20.6 µmol/L
STANDARD_DEVIATION 2.9 • n=69 Participants
|
20.7 µmol/L
STANDARD_DEVIATION 2.7 • n=138 Participants
|
|
Brachial blood pressure
Systolic
|
124 mmHg
STANDARD_DEVIATION 15 • n=69 Participants
|
125 mmHg
STANDARD_DEVIATION 11 • n=69 Participants
|
124 mmHg
STANDARD_DEVIATION 13 • n=138 Participants
|
|
Brachial blood pressure
Diastolic
|
79 mmHg
STANDARD_DEVIATION 8 • n=69 Participants
|
79 mmHg
STANDARD_DEVIATION 10 • n=69 Participants
|
79 mmHg
STANDARD_DEVIATION 9 • n=138 Participants
|
|
Central blood pressure
Systolic
|
114 mmHg
STANDARD_DEVIATION 14 • n=69 Participants
|
114 mmHg
STANDARD_DEVIATION 14 • n=69 Participants
|
114 mmHg
STANDARD_DEVIATION 12 • n=138 Participants
|
|
Central blood pressure
Diastolic
|
79 mmHg
STANDARD_DEVIATION 10 • n=69 Participants
|
80 mmHg
STANDARD_DEVIATION 8 • n=69 Participants
|
80 mmHg
STANDARD_DEVIATION 9 • n=138 Participants
|
|
Augmentation index @ 75bpm
|
22 percentage of aortic pulse pressure
STANDARD_DEVIATION 11 • n=69 Participants
|
21 percentage of aortic pulse pressure
STANDARD_DEVIATION 13 • n=69 Participants
|
22 percentage of aortic pulse pressure
STANDARD_DEVIATION 12 • n=138 Participants
|
|
Plasma glucose
|
97 mg/dL
STANDARD_DEVIATION 7 • n=69 Participants
|
98 mg/dL
STANDARD_DEVIATION 8 • n=69 Participants
|
98 mg/dL
STANDARD_DEVIATION 7.4 • n=138 Participants
|
|
Serum insulin
|
9.4 μIU/mL
STANDARD_DEVIATION 5.0 • n=69 Participants
|
8.8 μIU/mL
STANDARD_DEVIATION 3.5 • n=69 Participants
|
9.1 μIU/mL
STANDARD_DEVIATION 4.3 • n=138 Participants
|
|
HbA1C
|
5.5 percentage of glycated hemoglobin
STANDARD_DEVIATION 0.3 • n=69 Participants
|
5.5 percentage of glycated hemoglobin
STANDARD_DEVIATION 0.3 • n=69 Participants
|
5.5 percentage of glycated hemoglobin
STANDARD_DEVIATION 0.3 • n=138 Participants
|
|
Diet quality: Healthy Eating Index 2020
|
57.2 scores on a scale
STANDARD_DEVIATION 13.4 • n=69 Participants
|
55.1 scores on a scale
STANDARD_DEVIATION 10.7 • n=69 Participants
|
56.1 scores on a scale
STANDARD_DEVIATION 12.1 • n=138 Participants
|
|
Total Cholesterol concentration
|
194 mg/dL
STANDARD_DEVIATION 39 • n=69 Participants
|
190 mg/dL
STANDARD_DEVIATION 32 • n=69 Participants
|
192 mg/dL
STANDARD_DEVIATION 36 • n=138 Participants
|
PRIMARY outcome
Timeframe: 12 weeksMeasured by brachial ultrasound and expressed as percentage points of change in arterial diameter
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=67 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Flow Mediated Dilation
|
7.07 percent point change in arterial diamete
Standard Error 0.35
|
7.25 percent point change in arterial diamete
Standard Error 0.33
|
SECONDARY outcome
Timeframe: 12 weeksAssessed from fasting blood draw expressed in mg/dL
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
LDL-cholesterol Concentration
|
110 mg/dL
Standard Error 1.35
|
117 mg/dL
Standard Error 1.26
|
SECONDARY outcome
Timeframe: 12 weeksAssessed from fasting blood draw expressed in mg/dL
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
HDL-cholesterol Concentration
|
54 mg/dL
Standard Error 0.47
|
53 mg/dL
Standard Error 0.44
|
SECONDARY outcome
Timeframe: 12 weeksAssessed from fasting blood draw expressed in mg/dL
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Triglycerides
|
97.7 mg/dL
Interval 92.6 to 103.0
|
108 mg/dL
Interval 103.0 to 114.0
|
SECONDARY outcome
Timeframe: 12 weeksAssessed from fasting blood draw expressed in nmol/L. Data were log transformed and back transformed to improve residual distribution; Measure Description: LDL particle size classifications are as follows: 22-25.5 nm is small, 25.6-26.5 nm medium, and 26.6-28.5 nm large. Typically, smaller LDL is associated with increased cardiovascular risk compared to larger.
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
LDL Lipoprotein Subclasses
Large
|
281 nmol/L
Interval 249.0 to 317.0
|
252 nmol/L
Interval 225.0 to 281.0
|
|
LDL Lipoprotein Subclasses
Total
|
1248 nmol/L
Interval 1216.0 to 1280.0
|
1304 nmol/L
Interval 1273.0 to 1336.0
|
SECONDARY outcome
Timeframe: 12 weeksAssessed from fasting blood draw expressed in µmol/L; Measure Description: Size classifications of HDL subclasses are as follows: large (size 9.4-14.0 nm), medium (8.3-9.3 nm), and small (7.3-8.2 nm). Higher levels of large HDL may be inversely related to cardiovascular risk.
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
HDL Lipoprotein Subclasses
Medium
|
4.1 μmol/L
Standard Error 0.1
|
4.4 μmol/L
Standard Error 0.1
|
|
HDL Lipoprotein Subclasses
Small
|
14.1 μmol/L
Standard Error 0.2
|
14.3 μmol/L
Standard Error 0.2
|
|
HDL Lipoprotein Subclasses
Total
|
21.0 μmol/L
Standard Error 0.17
|
21.0 μmol/L
Standard Error 0.16
|
SECONDARY outcome
Timeframe: 12 weeksBlood pressure measured assessed using a SphygmoCor Xcel (Atcor Medical)
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Brachial Systolic and Diastolic Blood Pressure
Systolic
|
125 mmHg
Standard Error 0.81
|
125 mmHg
Standard Error 0.77
|
|
Brachial Systolic and Diastolic Blood Pressure
Diastolic
|
79 mmHg
Standard Error 0.50
|
79 mmHg
Standard Error 0.47
|
SECONDARY outcome
Timeframe: 12 weeksBlood pressure measured assessed using a SphygmoCor Xcel (Atcor Medical)
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Central Systolic and Diastolic Blood Pressure
Systolic
|
114 mmHg
Standard Error 0.70
|
115 mmHg
Standard Error 0.69
|
|
Central Systolic and Diastolic Blood Pressure
Diastolic
|
80 mmHg
Standard Error 0.50
|
80 mmHg
Standard Error 0.48
|
SECONDARY outcome
Timeframe: 12 weeksA measure of arterial stiffness assessed using a SphygmoCor Xcel (Atcor Medical). Expressed in meters/second. Higher values indicate greater arterial stiffness
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Carotid-femoral Pulse Wave Velocity
|
7.1 m/s
Standard Deviation 1.3
|
7.3 m/s
Standard Deviation 1.3
|
SECONDARY outcome
Timeframe: 12 weeksA measure of arterial stiffness assessed using a SphygmoCor Xcel (Atcor Medical). Expressed as a percentage. A higher percentage value is indicative of greater arterial stiffness. Measure Description: Augmentation index is a measure of arterial stiffening that correlates with CVD risk. Higher augmentation index, used as a surrogate for wave reflection, is indicative of additional load on the left ventricle. Augmentation index is calculated as augmentation pressure/pulse pressure\*100 to provide a percent. We utilized the Sphymocor Xcel for this measure. We used standardized augmentation index at 75 bpm for heart rate.
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Augmentation Index@75bpm
|
21 percentage of aortic pulse pressure
Standard Error 0.65
|
22 percentage of aortic pulse pressure
Standard Error 0.65
|
SECONDARY outcome
Timeframe: 12 weeksFasting blood glucose assessed by blood draw and expressed in mg/dL
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Fasting Plasma Glucose Concentration
|
97.7 mg/dL
Standard Error 0.48
|
96.7 mg/dL
Standard Error 0.45
|
SECONDARY outcome
Timeframe: 12 weeksFasting serum insulin levels assessed by blood draw and expressed in micro IU/m
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Serum Insulin Concentration
|
8.42 μIU/mL
Interval 7.92 to 8.95
|
8.33 μIU/mL
Interval 7.87 to 8.83
|
SECONDARY outcome
Timeframe: 12-weeksHbA1c assessed in whole blood collected during fasting
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
HbA1c
|
5.53 percentage of glycated hemoglobin
Standard Error 0.01
|
5.49 percentage of glycated hemoglobin
Standard Error 0.01
|
SECONDARY outcome
Timeframe: 12-weeksDiet quality measured by 24-hour recalls will be assessed using Health Eating Index 2020 (HEI-2020) scores range from 0-100 with 100 indicating perfect adherence to dietary guidelines and 0 indicating no adherence. The HEI-2020 includes 13 components; 9 components are adequacy (i.e., consuming more results in a higher score), and 4 are moderation (i.e., consuming less results in a higher score). The HEI-2020 was calculated with the Statistical Analysis System (SAS) code from the National Cancer Institute.
Outcome measures
| Measure |
Pecan Group
n=65 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=67 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Diet Quality: Healthy Eating Index 2020
|
60.8 scores on a scale
Standard Error 1.1
|
51.5 scores on a scale
Standard Error 1.0
|
SECONDARY outcome
Timeframe: 12-weeksAssessed from fasting blood draw expressed in mg/dL
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Total Cholesterol Concentration
|
185 mg/dL
Standard Error 1.69
|
193 mg/dL
Standard Error 1.59
|
SECONDARY outcome
Timeframe: 12 weeksLDL subclasses with normal distribution; Measure Description: LDL particle size classifications are as follows: 22-25.5 nm is small, 25.6-26.5 nm medium, and 26.6-28.5 nm large. Typically, smaller LDL is associated with increased cardiovascular risk compared to larger.
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
LDL Subclasses
Medium
|
297 nmol/L
Standard Error 20.2
|
337 nmol/L
Standard Error 19.1
|
|
LDL Subclasses
Small
|
684 nmol/L
Standard Error 24.5
|
677 nmol/L
Standard Error 23.2
|
SECONDARY outcome
Timeframe: 12 weeksMeasure was log transformed and back transformed to improve distribution; results for large HDL subclass are presented; Measure Description: Size classifications of HDL subclasses are as follows: large (size 9.4-14.0 nm), medium (8.3-9.3 nm), and small (7.3-8.2 nm). Higher levels of large HDL may be inversely related to cardiovascular risk.
Outcome measures
| Measure |
Pecan Group
n=62 Participants
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=68 Participants
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
HDL Subclass-Large
|
2.2 μmol/L
Interval 2.0 to 2.3
|
2.0 μmol/L
Interval 1.8 to 2.1
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 12 weeksAbundance measured using 16 s rRNA sequencing
Outcome measures
Outcome data not reported
Adverse Events
Pecan Group
Usual Care Group
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Pecan Group
n=69 participants at risk
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Pecans: Participants will receive 2 oz of pecans daily to replace a typical snack and continue consuming their usual diet for 12 weeks.
|
Usual Care Group
n=69 participants at risk
Participants will consume their usual diet devoid of nuts
Usual Care: Participants will receive grocery vouchers and continue consuming their usual diet for 12 weeks.
|
|---|---|---|
|
Gastrointestinal disorders
Appendectomy
|
1.4%
1/69 • Number of events 1 • 3 months
No deaths occurred no serious adverse events occurred.
|
0.00%
0/69 • 3 months
No deaths occurred no serious adverse events occurred.
|
|
Gastrointestinal disorders
Gastric resection
|
1.4%
1/69 • Number of events 1 • 3 months
No deaths occurred no serious adverse events occurred.
|
0.00%
0/69 • 3 months
No deaths occurred no serious adverse events occurred.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place